1Gatenby RA. A change of strategy in the war on cancer [J].Nature, 2009,459(7246): 508-509.
2汤钊猷.现代肿瘤学[M].3版.上海:复旦大学出版社,2011:890-931.
3Pierce JN. Multiple diversity with nonindependent fading[J].Proceedings of the IRE, 1960(48): 89-104.
4Sachs L. The differentiation of myeloid leukaemia cells: newpossibilities for therapy[J]. Br J Haematol, 1978, 40(4) : 509-517.
5Leszczyniecka M, Roberts T, Dent P, et al. Differentiation therapyof human cancer : basic science and clinical applicat ions[J].Pharmacol Ther, 2001, 90(2/3): 105-156.
6Huang ME. Use of all-trans retinoic acid in the treatment ofacute promyelocytic leukemia[J]. Blood, 1988,72(2): 567-572.
8[1]Leszczyniecka M, Roberts T, Dent P, et al. Differentiation therapy of human cancer: basic science and clinical applications[J]. Pharmacol Ther, 2001,90(2-3): 105-156.
9[3]Basak R, Basu M, Chatterjee M. Combined supplementation of vanadium and lalpha, 25-dihydroxyvitamin D (3) inhibit diethylnitrosamine-induced rat liver carcinogenesis [J]. Chem Biol Interact,2000,128(1):1-18.
10[4]Ortiz MA, Bayou Y, Lopez-Hernandez FJ, et al. Retinoids in combination therapies for the treatment of cancer:mechanisms and perspectives [J]. Drug Resist Updat,2002,5 (3-4): 162-175.
